Previously, the team discovered a chemical probe that pinpoints where bacterial cells build the polymer that strengthens their walls, called peptidoglycan. The discovery may hold the key to fighting antibiotic-resistant bacteria, according to lead chemist, Michael VanNieuwenhze, PhD.
“If you can see how something is being built, you have a better chance of being able to develop ways to interfere with the building process,” said Dr. VanNieuwenhze.
Agreeing with the team’s assessment, the National Institutes of Health awarded them the grant to improve upon their method of examining the dynamics of how cells build peptidoglycan. The team will use the grant to develop better probes to capture images of peptidoglycan construction in E. coli, the bacteria organism Bacillus subtilis and the pathogen Streptococcus pneumoniae.
S. pneumoniae is responsible for roughly 4 million infections — including 1.2 million drug-resistant infections — and 22,000 deaths in the U.S. every year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
